{"filing":{"accession_number":"0001493152-26-032155","cik":"0001174940","ticker":"OGEN","company_name":"ORAGENICS INC","form":"8-K","filing_date":"2026-07-06","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315226032155/form8-k.htm"},"events":[{"id":17090,"run_id":15299,"accession_number":"0001493152-26-032155","anchor_item_number":"1.01","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"Item 1.01 discloses the appointment of John Spencer, the Company's Senior Controller, to serve as Chief Financial Officer effective July 1, 2026, along with an Executive Employment Agreement. While Item 5.02(e) also mentions compensatory arrangements (an option award of $25,000), the principal disclosed action in Item 1.01 is the appointment to the CFO role, making exec_appointment the most salient classification. The appointment of a CFO is material to investors as it affects the registrant's financial leadership and governance.","company_name":"ORAGENICS INC","ticker":"OGEN","filing_date":"2026-07-06","form":"8-K","submitted_at":null,"items":[{"id":15408,"accession_number":"0001493152-26-032155","item_number":"1.01","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"Item 1.01 discloses the appointment of John Spencer, the Company's Senior Controller, to serve as Chief Financial Officer effective July 1, 2026, along with an Executive Employment Agreement. While Item 5.02(e) also mentions compensatory arrangements (an option award of $25,000), the principal disclosed action in Item 1.01 is the appointment to the CFO role, making exec_appointment the most salient classification. The appointment of a CFO is material to investors as it affects the registrant's financial leadership and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T12:51:22.181962+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":15408,"accession_number":"0001493152-26-032155","item_number":"1.01","item_title":null,"event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"Item 1.01 discloses the appointment of John Spencer, the Company's Senior Controller, to serve as Chief Financial Officer effective July 1, 2026, along with an Executive Employment Agreement. While Item 5.02(e) also mentions compensatory arrangements (an option award of $25,000), the principal disclosed action in Item 1.01 is the appointment to the CFO role, making exec_appointment the most salient classification. The appointment of a CFO is material to investors as it affects the registrant's financial leadership and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T12:51:22.181962+00:00","company_name":"ORAGENICS INC","ticker":"OGEN","filing_date":"2026-07-06"}]}